129 related articles for article (PubMed ID: 28536608)
1. Nuclear expression of TCF4/TCF7L2 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma.
Ishiguro H; Wakasugi T; Terashita Y; Sakamoto N; Tanaka T; Sagawa H; Okubo T; Takeyama H
Cell Mol Biol Lett; 2016; 21():5. PubMed ID: 28536608
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of CDH1 or CTNNB1 affects poor prognosis of patients with esophageal cancer.
Ishiguro H; Wakasugi T; Terashita Y; Sakamoto N; Tanaka T; Mizoguchi K; Sagawa H; Okubo T; Takeyama H
World J Surg Oncol; 2016 Sep; 14(1):240. PubMed ID: 27600761
[TBL] [Abstract][Full Text] [Related]
3. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.
Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS
Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075
[TBL] [Abstract][Full Text] [Related]
4. TCF7L2 and EGR1 synergistic activation of transcription of LCN2 via an ERK1/2-dependent pathway in esophageal squamous cell carcinoma cells.
Zhao Y; Xia Q; Liu Y; Bai W; Yao Y; Ding J; Lin L; Xu Z; Cai Z; Wang S; Li E; Xu H; Wu B; Xu L; Du Z
Cell Signal; 2019 Mar; 55():8-16. PubMed ID: 30557604
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of uc.189 in patients with esophageal squamous cell carcinoma and its clinicopathologic value.
Guo Y; Wang C; Miao X; Chen S; Qian Y; Li G; Jiang Y
Pathol Res Pract; 2017 Nov; 213(11):1400-1403. PubMed ID: 28941722
[TBL] [Abstract][Full Text] [Related]
6. Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma.
Yokobori T; Bao P; Fukuchi M; Altan B; Ozawa D; Rokudai S; Bai T; Kumakura Y; Honjo H; Hara K; Sakai M; Sohda M; Miyazaki T; Ide M; Nishiyama M; Oyama T; Kuwano H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1566-73. PubMed ID: 26310281
[TBL] [Abstract][Full Text] [Related]
7. HIF-1α stimulates the progression of oesophageal squamous cell carcinoma by activating the Wnt/β-catenin signalling pathway.
Tang K; Toyozumi T; Murakami K; Sakata H; Kano M; Endo S; Matsumoto Y; Suito H; Takahashi M; Sekino N; Otsuka R; Kinoshita K; Hirasawa S; Hu J; Uesato M; Hayano K; Matsubara H
Br J Cancer; 2022 Aug; 127(3):474-487. PubMed ID: 35484214
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma.
Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG
Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in Chinese patients with esophageal squamous cell carcinoma.
Cui Y; Dong C; Wu BQ; Duan XC; Shi G; Gong M; Wang TY
J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C44-8. PubMed ID: 26323923
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of matrix metalloproteinase 10 is associated with poor survival in patients with early stage of esophageal squamous cell carcinoma.
Liu H; Qin YR; Bi J; Guo A; Fu L; Guan XY
Dis Esophagus; 2012; 25(7):656-63. PubMed ID: 22121946
[TBL] [Abstract][Full Text] [Related]
11. [Expression of FBXW7 in esophageal squamous cell carcinoma and its clinical significance].
Yu H; Ling T; Shi R; Shu Q; Li Y; Tan Z
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):347-51. PubMed ID: 26463024
[TBL] [Abstract][Full Text] [Related]
12. Expression of kallikrein-related peptidase 13 is associated with poor prognosis in esophageal squamous cell carcinoma.
Nohara K; Yamada K; Yamada L; Hagiwara T; Igari T; Yokoi C; Soma D; Yamashita S; Dohi T; Kawamura YI
Gen Thorac Cardiovasc Surg; 2018 Jun; 66(6):351-357. PubMed ID: 29582368
[TBL] [Abstract][Full Text] [Related]
13. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
Liu L; Yang Z; Ni W; Xuan Y
Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
[TBL] [Abstract][Full Text] [Related]
14. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S
Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007
[TBL] [Abstract][Full Text] [Related]
15. Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis.
Zheng J; Xu C; Chu D; Zhang X; Li J; Ji G; Hong L; Feng Q; Li X; Wu G; Du J; Zhao Q
Immunol Lett; 2014 Sep; 161(1):13-9. PubMed ID: 24768599
[TBL] [Abstract][Full Text] [Related]
16. Predictive Value of LINC01133 for Unfavorable Prognosis was Impacted by Alcohol in Esophageal Squamous Cell Carcinoma.
Yang XZ; He QJ; Cheng TT; Chi J; Lei ZY; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
Cell Physiol Biochem; 2018; 48(1):251-262. PubMed ID: 30007982
[TBL] [Abstract][Full Text] [Related]
17. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma.
Wang Y; Liu S; Zhu H; Zhang W; Zhang G; Zhou X; Zhou C; Quan L; Bai J; Xue L; Lu N; Xu N
Int J Cancer; 2008 Aug; 123(3):561-8. PubMed ID: 18498136
[TBL] [Abstract][Full Text] [Related]
18. RANK overexpression as a novel esophageal cancer marker: validated immunohistochemical analysis of two different ethnicities.
Cui X; Peng H; Jin J; Li T; Zhang S; Jin T; Li S; Liu C; Liang W; Li F; Chen Y
Int J Clin Exp Pathol; 2015; 8(2):2249-58. PubMed ID: 25973136
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of activator of G-protein signaling 3 decreases the proliferation of esophageal squamous cell carcinoma.
Shi H; Ren H; Yang X; Zhu H; Yao L; Hang Q; Mao H; Huang Y; Zhang J; Wang Y
Pathol Res Pract; 2015 Jun; 211(6):449-55. PubMed ID: 25812748
[TBL] [Abstract][Full Text] [Related]
20. κ-Opioid receptor in the nucleus is a novel prognostic factor of esophageal squamous cell carcinoma.
Zhang YF; Xu QX; Liao LD; Xu XE; Wu JY; Shen J; Wu ZY; Shen JH; Li EM; Xu LY
Hum Pathol; 2013 Sep; 44(9):1756-65. PubMed ID: 23574786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
